Cerebral Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Cerebral Therapeutics's estimated annual revenue is currently $4.8M per year.
- Cerebral Therapeutics's estimated revenue per employee is $201,000
Employee Data
- Cerebral Therapeutics has 24 Employees.
- Cerebral Therapeutics grew their employee count by -20% last year.
Cerebral Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Clinical Development | Reveal Email/Phone |
2 | Sr Director, Pharmaceutical Development | Reveal Email/Phone |
3 | Chief Scientific Officer | Reveal Email/Phone |
4 | Director | Reveal Email/Phone |
5 | Chief Financial Officer | Reveal Email/Phone |
6 | Senior Director Quality and Device Development | Reveal Email/Phone |
7 | Chief Operating Officer | Reveal Email/Phone |
8 | Senior Product Development Project Manager | Reveal Email/Phone |
9 | Principal Systems Engineer | Reveal Email/Phone |
10 | President, Cerebral Therapeutics, Inc. | Reveal Email/Phone |
Cerebral Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5M | 25 | 0% | N/A | N/A |
#2 | $10.3M | 51 | 6% | N/A | N/A |
#3 | $4.4M | 22 | -8% | N/A | N/A |
#4 | $195M | 122 | 0% | $121.4M | N/A |
#5 | $4.8M | 24 | -20% | N/A | N/A |
#6 | $6.8M | 34 | -19% | N/A | N/A |
#7 | $4.8M | 24 | 0% | N/A | N/A |
#8 | $4M | 40 | -11% | $138M | N/A |
#9 | $4.8M | 24 | -14% | N/A | N/A |
#10 | $69.5M | 346 | -6% | N/A | N/A |
What Is Cerebral Therapeutics?
Cerebral Therapeutics, Inc. is a clinical-stage pharmaceutical company dedicated to improving the lives of patients living with severe refractory epilepsy and other uncontrolled neurological diseases. Founded by experts in the fields of neurology, neurosurgery, and drug delivery, the Company is pioneering the development of drug-device combination therapies that enable precise targeted delivery to the central nervous system.
keywords:N/AN/A
Total Funding
24
Number of Employees
$4.8M
Revenue (est)
-20%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Cerebral Therapeutics News
Ischemic Cerebral Stroke Prevention Therapeutics Market Size, Outlook And Forecast | Johnson & Johnson, Boston Therapeutics, Edge Therapeutics, Zocere, Lundbeck...
Cerebral Malaria Therapeutics Market Size, Outlook And Forecast | Novartis, Cipla, Zydus Cadila, Ipca Laboratories, Sanofi, Eisai. Photo of...
Argenica Therapeutics ASX AGN positive results ARG-007 study cerebral ischaemia Argenica chief executive officer Dr Liz Dallimore says the...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 24 | 0% | N/A |
#2 | $5.1M | 24 | -4% | N/A |
#3 | $5.5M | 24 | 9% | N/A |
#4 | $4.2M | 24 | -45% | N/A |
#5 | $3M | 24 | 4% | N/A |